Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2017-11-01
Saila:BMC Cancer
Gaiak:
Neuroendocrine prostate cancer
Small cell carcinoma
Mixed prostatic adenocarcinoma
FFPE
Gene signature
Meta-analysis
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s12885-017-3729-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak